Market revenue in 2022 | USD 310.0 million |
Market revenue in 2030 | USD 857.1 million |
Growth rate | 13.6% (CAGR from 2022 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Quality Assurance |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quality Assurance, Regulatory Affairs Services, Product Design and Development Services, Product Testing & Sterilization Services, Product Implementation Services, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device outsourcing market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 54.74% in 2022. Horizon Databook has segmented the Singapore medical device outsourcing market based on quality assurance, regulatory affairs services, product design and development services, product testing & sterilization services, product implementation services, product upgrade services, product maintenance services, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of chronic diseases is one of the key factors responsible for market growth in the country. According to the Ministry of Health in October 2022, by 2030, one in every four people in Singapore will be 65 or older. As chronic illnesses are more prevalent in older individuals, aging will increase the disease burden.
This is projected to increase the demand for medical devices in the country, thus creating opportunities for market players. Singapore is a relatively smaller market for medical devices. However, the country has a talented pool of researchers, scientists, and engineers.
This is supported by highly developed electronics and precision engineering infrastructure, as well as the strong presence of support services such as logistics and sterilization companies. This is expected to boost the interest of new entrants in entering Singapore market. Some key players operating in the country are ClinActis Pte. Ltd., SGS SA, and Charles River Laboratories.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore medical device outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Singapore medical device outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account